Katsuhiro Hayashi
- Biotechnology top 0.1%
- Cancer Research and Treatments 83
- Hepatology top 1%
- Rheumatology top 1%
- Bone Tumor Diagnosis and Treatments 64
-
- Sarcoma Diagnosis and Treatment 124
- Oncology top 2%
- Vascular Tumors and Angiosarcomas 18
-
- Virus-based gene therapy research 50
-
- Nanoplatforms for cancer theranostics 40
-
- Management of metastatic bone disease 18
-
- Cardiac tumors and thrombi 17
- Co-authors
- Hiroyuki TsuchiyaNorio YamamotoAkihiko TakeuchiShinji MiwaRobert M. HoffmanKentaro IgarashiMichael BouvetKatsuro Tomita
- Cited by
- BiotechnologyHepatologyRheumatology
- Partner nations
- JapanUnited StatesEgypt
In The Last Decade
Katsuhiro Hayashi
295 papers receiving 6.2k citations
Peers
Comparison fields: 5 of 131
- Biotechnology 1.4k
- Hepatology 654
- Rheumatology 957
- Pulmonary and Respiratory Medicine 1.7k
- Oncology 1.2k
Countries citing papers authored by Katsuhiro Hayashi
This map shows the geographic impact of Katsuhiro Hayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katsuhiro Hayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katsuhiro Hayashi more than expected).
Fields of papers citing papers by Katsuhiro Hayashi
This network shows the impact of papers produced by Katsuhiro Hayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katsuhiro Hayashi. The network helps show where Katsuhiro Hayashi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Katsuhiro Hayashi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 13 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 0 | |
| 7 | 2022 | 18 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 4 | |
| 10 | 2022 | 16 | |
| 11 | 2022 | 4 | |
| 12 | 2021 | 10 | |
| 13 | 2021 | 1 | |
| 14 | 2019 | 35 | |
| 15 | 2019 | 26 | |
| 16 | 2018 | 26 | |
| 17 | Synovial sarcoma in knee joint, mimicking low-grade sarcoma confirmed by molecular detection of SYT gene split. | 2014 | 5 |
| 18 | 2009 | 119 | |
| 19 | 2007 | 107 | |
| 20 | [Progress of anthocyanin research in Japan with special reference to paper chromatographic method]. | 1957 | 2 |
About Katsuhiro Hayashi
Katsuhiro Hayashi is a scholar working on Biotechnology, Rheumatology and Pulmonary and Respiratory Medicine, having authored 314 papers that have together received 6.3k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (124 papers), Cancer Research and Treatments (83 papers), Bone Tumor Diagnosis and Treatments (64 papers), Virus-based gene therapy research (50 papers), Nanoplatforms for cancer theranostics (40 papers), Vascular Tumors and Angiosarcomas (18 papers), Management of metastatic bone disease (18 papers) and Cardiac tumors and thrombi (17 papers). The work is most often cited by research in Biotechnology (1.4k citations), Hepatology (654 citations) and Rheumatology (957 citations). Katsuhiro Hayashi has collaborated with scholars based in Japan, United States and Egypt. Frequent co-authors include Hiroyuki Tsuchiya, Norio Yamamoto, Akihiko Takeuchi, Shinji Miwa, Robert M. Hoffman, Kentaro Igarashi, Michael Bouvet, Katsuro Tomita, Hirohito Tsubouchi and Toshiharu Shirai.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.